We report a case in which low-dose FP (5-fluorouracil/cisplatin, 5-FU/CDDP) therapy was remarkably effective for stage IVB advanced hepatocellular carcinoma (HCC) with lung and bone metastases. 5-FU of 250 mg/body/day was continuously infused over 24 hours and CDDP of 10 mg/body/day ...
肉眼的門脈侵襲陽性肝癌切除後のSystemic IFN+Low dose FP の有用性 : 理論的根拠と臨床的効果Background and Aims : Despite a recent progress of treatment for hepatocellular carcinoma (HCC), the prognosis of advanced HCC with macroscopic ... 居村 暁,花岡 潤,金本 真美,... 被引量: 0发表: 201...
Therapeutic options for patients with advanced hepatocellular carcinoma (HCC) are limited. There is emerging evidence that the growth of cancer cells may b... FP Costa,AC De Oliveira,R Meirelles,... - 《British Journal of Cancer》 被引量: 97发表: 2011年 Long-term efficacy and toxicity of ...
After hepatic resection for HCC, the metastatic tumor progressed and became multiple lesions with mediastinal lymphnode involvements. Low-dose FP therapy was performed. Then, 250 mg/m(2)/day of 5-fluorouracil was given intravenously for 5 days weekly by continuous infusion and 10 mg/m(2)/day...
Methods: Sixty- eight patients with unresectable and nonembolizable HCC were consecutively enrolled in a compassionate treatment program of oral thalidomide. Tumor response and treatment- related toxicity were prospectively followed. Thalidomide was given at a starting dose of 200 mg per day. The dose...
Toxicities of thalidomide were generally manageable, and only 16, 6, and 0 patients developed grade 2, 3, and 4 toxicities, respectively.Low-dose thalidomide is safe and induces unequivocal tumor response in a minority of patients with advanced HCC.Chiun...
. Thinking in epidemiological terms often seems strange to clinicians who are used to think of the problem of each single patient.doi:10.1007/978-3-662-08422-9_5Professor Dr. Dr. h.c. Christian StrefferH. BoltD. FøllesdalP. HallE. SwatonSpringer Berlin Heidelberg...
Therefore it was very soon necessary to determine standards and dose limits for ionising radiation for persons at working places and later, also for individuals of the general population. The first standards were defined in the twenties and developed during the 20 th century based on that ...
MAFLD not only affects liver health, having become one of the primary causes of hepatocellular carcinoma (HCC), but also increases the risk of different kinds of diseases [1,7,8]. However, MAFLD still has no approved drug therapy. This means that it is particularly important to treat MAFLD...
cancers Article DUOX2, a New Biomarker for Disseminated Gastric Cancer's Response to Low Dose Radiation in Mice Palak R. Parekh 1,2, Eduardo Solano-Gonzalez 1,2, Mariana B. Martins 2,3, Xinrong Ma 4, Kayla Tighe 4, Andrea Casildo 4, Andrew Zodda 2, Christopher Johnstone 2, Yannick ...